Profile | GDS5420 / 34260_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1213.64 | 82 |
GSM1296119 | B_lesional_pre-dose | 259.66 | 56 |
GSM1296076 | C_lesional_pre-dose | 255.21 | 58 |
GSM1296092 | D_lesional_pre-dose | 437.78 | 66 |
GSM1296103 | E_lesional_pre-dose | 902.87 | 77 |
GSM1296078 | F_lesional_pre-dose | 262.06 | 59 |
GSM1296107 | G_lesional_pre-dose | 370.95 | 63 |
GSM1296109 | H_lesional_pre-dose | 672.69 | 73 |
GSM1296080 | I_lesional_pre-dose | 1230.87 | 82 |
GSM1296090 | J_lesional_pre-dose | 434.04 | 66 |
GSM1296074 | K_lesional_pre-dose | 266.82 | 59 |
GSM1296111 | L_lesional_pre-dose | 273.56 | 57 |
GSM1296099 | M_lesional_pre-dose | 669.09 | 72 |
GSM1296086 | O_lesional_pre-dose | 455 | 67 |
GSM1296117 | P_lesional_pre-dose | 427.87 | 65 |
GSM1296113 | Q_lesional_pre-dose | 339.19 | 60 |
GSM1296096 | R_lesional_pre-dose | 543.52 | 69 |
GSM1296105 | S_lesional_pre-dose | 556.69 | 69 |
GSM1296098 | T_lesional_pre-dose | 1291.41 | 83 |
GSM1296101 | U_lesional_pre-dose | 630.4 | 71 |
GSM1296121 | V_lesional_pre-dose | 308.27 | 59 |
GSM1296088 | W_lesional_pre-dose | 534.05 | 69 |
GSM1296082 | X_lesional_pre-dose | 464 | 67 |
GSM1296115 | Y_lesional_pre-dose | 371.86 | 63 |
GSM1296084 | Z_lesional_pre-dose | 733.09 | 74 |
GSM1296072 | B_lesional_day8 | 277.01 | 57 |
GSM1296069 | L_lesional_day8 | 331.14 | 60 |
GSM1296071 | P_lesional_day8 | 450.5 | 65 |
GSM1296070 | Y_lesional_day8 | 366.09 | 62 |
GSM1296073 | V_lesional_day8 | 246.88 | 56 |
GSM1296034 | A_lesional_day15 | 1816.17 | 89 |
GSM1296041 | G_lesional_day15 | 268.44 | 57 |
GSM1296035 | R_lesional_day15 | 512.85 | 68 |
GSM1296038 | U_lesional_day15 | 329.73 | 61 |
GSM1296047 | B_lesional_day15 | 269.34 | 56 |
GSM1296039 | E_lesional_day15 | 335.87 | 61 |
GSM1296042 | H_lesional_day15 | 318.23 | 60 |
GSM1296043 | L_lesional_day15 | 314.35 | 59 |
GSM1296037 | M_lesional_day15 | 785.93 | 75 |
GSM1296046 | P_lesional_day15 | 233.29 | 53 |
GSM1296044 | Q_lesional_day15 | 314.93 | 59 |
GSM1296045 | Y_lesional_day15 | 312.92 | 59 |
GSM1296025 | C_lesional_day15 | 654.38 | 72 |
GSM1296033 | D_lesional_day15 | 514.85 | 68 |
GSM1296027 | I_lesional_day15 | 641.48 | 72 |
GSM1296032 | J_lesional_day15 | 752.49 | 74 |
GSM1296024 | K_lesional_day15 | 585.43 | 70 |
GSM1296031 | W_lesional_day15 | 537.31 | 69 |
GSM1296028 | X_lesional_day15 | 715.03 | 73 |
GSM1296029 | Z_lesional_day15 | 796.87 | 75 |
GSM1296026 | F_lesional_day15 | 382.96 | 64 |
GSM1296030 | O_lesional_day15 | 687.57 | 73 |
GSM1296040 | S_lesional_day15 | 777.8 | 75 |
GSM1296036 | T_lesional_day15 | 949.57 | 78 |
GSM1296048 | V_lesional_day15 | 276.04 | 57 |
GSM1296059 | A_lesional_day43 | 946.5 | 78 |
GSM1296066 | G_lesional_day43 | 279.61 | 57 |
GSM1296060 | R_lesional_day43 | 444.68 | 66 |
GSM1296063 | U_lesional_day43 | 258.88 | 57 |
GSM1296064 | E_lesional_day43 | 354.48 | 62 |
GSM1296067 | H_lesional_day43 | 462.13 | 66 |
GSM1296062 | M_lesional_day43 | 1159.18 | 81 |
GSM1296068 | Q_lesional_day43 | 321.68 | 59 |
GSM1296050 | C_lesional_day43 | 312.39 | 60 |
GSM1296057 | D_lesional_day43 | 599.33 | 70 |
GSM1296052 | I_lesional_day43 | 614.3 | 71 |
GSM1296054 | J_lesional_day43 | 850.53 | 76 |
GSM1296049 | K_lesional_day43 | 550.19 | 69 |
GSM1296055 | W_lesional_day43 | 312.47 | 59 |
GSM1296053 | X_lesional_day43 | 983.34 | 79 |
GSM1296058 | Z_lesional_day43 | 665.26 | 72 |
GSM1296051 | F_lesional_day43 | 355.72 | 63 |
GSM1296056 | O_lesional_day43 | 558.01 | 70 |
GSM1296065 | S_lesional_day43 | 394.44 | 63 |
GSM1296061 | T_lesional_day43 | 1483.86 | 85 |
GSM1296095 | A_non-lesional_pre-dose | 480.2 | 67 |
GSM1296120 | B_non-lesional_pre-dose | 239.35 | 54 |
GSM1296077 | C_non-lesional_pre-dose | 451.89 | 66 |
GSM1296093 | D_non-lesional_pre-dose | 737.98 | 74 |
GSM1296104 | E_non-lesional_pre-dose | 357.54 | 62 |
GSM1296079 | F_non-lesional_pre-dose | 471.51 | 67 |
GSM1296108 | G_non-lesional_pre-dose | 307.08 | 59 |
GSM1296110 | H_non-lesional_pre-dose | 369.69 | 61 |
GSM1296081 | I_non-lesional_pre-dose | 1478.1 | 85 |
GSM1296091 | J_non-lesional_pre-dose | 472.36 | 67 |
GSM1296075 | K_non-lesional_pre-dose | 271.59 | 59 |
GSM1296112 | L_non-lesional_pre-dose | 390.1 | 63 |
GSM1296100 | M_non-lesional_pre-dose | 952.22 | 78 |
GSM1296087 | O_non-lesional_pre-dose | 362.36 | 63 |
GSM1296118 | P_non-lesional_pre-dose | 407.61 | 63 |
GSM1296114 | Q_non-lesional_pre-dose | 281.49 | 57 |
GSM1296097 | R_non-lesional_pre-dose | 287.71 | 58 |
GSM1296106 | S_non-lesional_pre-dose | 455.64 | 66 |
GSM1296102 | U_non-lesional_pre-dose | 532.74 | 68 |
GSM1296122 | V_non-lesional_pre-dose | 254.26 | 55 |
GSM1296089 | W_non-lesional_pre-dose | 430.06 | 65 |
GSM1296083 | X_non-lesional_pre-dose | 1446.15 | 85 |
GSM1296116 | Y_non-lesional_pre-dose | 293.08 | 57 |
GSM1296085 | Z_non-lesional_pre-dose | 811.83 | 76 |